Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[161Tb]Tb-PSMA-617 radioligand therapy in patients with mCRPC: preliminary dosimetry results and intra-individual head-to-head comparison to [177Lu]Lu-PSMA-617.
Schaefer-Schuler A, Burgard C, Blickle A, Maus S, Petrescu C, Petto S, Bartholomä M, Stemler T, Ezziddin S, Rosar F. Schaefer-Schuler A, et al. Among authors: petto s. Theranostics. 2024 Feb 24;14(5):1829-1840. doi: 10.7150/thno.92273. eCollection 2024. Theranostics. 2024. PMID: 38505615 Free PMC article.
[89Zr]Zr-PSMA-617 PET/CT characterization of indeterminate [68Ga]Ga-PSMA-11 PET/CT findings in patients with biochemical recurrence of prostate cancer: lesion-based analysis.
Rosar F, Burgard C, Larsen E, Khreish F, Marlowe RJ, Schaefer-Schuler A, Maus S, Petto S, Bartholomä M, Ezziddin S. Rosar F, et al. Among authors: petto s. Cancer Imaging. 2024 Feb 22;24(1):27. doi: 10.1186/s40644-024-00671-1. Cancer Imaging. 2024. PMID: 38389092 Free PMC article.
Change in total lesion PSMA (TLP) during [177Lu]Lu-PSMA-617 radioligand therapy predicts overall survival in patients with mCRPC: monocentric evaluation of a prospective registry.
Burgard C, Hein C, Blickle A, Bartholomä M, Maus S, Petto S, Schaefer-Schuler A, Ezziddin S, Rosar F. Burgard C, et al. Among authors: petto s. Eur J Nucl Med Mol Imaging. 2024 Feb;51(3):885-895. doi: 10.1007/s00259-023-06476-x. Epub 2023 Oct 27. Eur J Nucl Med Mol Imaging. 2024. PMID: 37889298 Free PMC article.
[89Zr]Zr-PSMA-617 PET/CT in biochemical recurrence of prostate cancer: first clinical experience from a pilot study including biodistribution and dose estimates.
Rosar F, Schaefer-Schuler A, Bartholomä M, Maus S, Petto S, Burgard C, Privé BM, Franssen GM, Derks YHW, Nagarajah J, Khreish F, Ezziddin S. Rosar F, et al. Among authors: petto s. Eur J Nucl Med Mol Imaging. 2022 Nov;49(13):4736-4747. doi: 10.1007/s00259-022-05925-3. Epub 2022 Aug 5. Eur J Nucl Med Mol Imaging. 2022. PMID: 35930033 Free PMC article.
Evaluation of different platforms for the detection of anti-SARS coronavirus-2 antibodies, Thailand.
Lerdsamran H, Mungaomklang A, Iamsirithaworn S, Prasertsopon J, Prasert K, Intalapaporn P, Siriyakorn N, Wiriyarat W, Thinpan N, Sawadpongpan S, Sirikhetkon S, Mongkalangoon N, Petto S, Puthavathana P. Lerdsamran H, et al. Among authors: petto s. BMC Infect Dis. 2021 Dec 6;21(1):1213. doi: 10.1186/s12879-021-06921-y. BMC Infect Dis. 2021. PMID: 34872510 Free PMC article.